Cargando…

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma

The impact of radiotherapy (RT) quality assurance (QA) has been demonstrated by numerous studies and is particularly important for head and neck cancer (HNC) treatment due to the complexity of RT target volumes in this region and the multiple adjacent organs at risk. The RT planning process includes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Gestel, Dirk, Dragan, Tatiana, Grégoire, Vincent, Evans, Mererid, Budach, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081058/ https://www.ncbi.nlm.nih.gov/pubmed/32226773 http://dx.doi.org/10.3389/fonc.2020.00282

Ejemplares similares

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
por: Zhong, Haoyu, et al.
Publicado: (2019)

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment
por: Vermorken, Jan B., et al.
Publicado: (2021)

Quality assurance of registration of CT and MRI data sets for treatment planning of radiotherapy for head and neck cancers
por: Moore, Craig S., et al.
Publicado: (2004)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
por: Budach, W, et al.
Publicado: (2006)

Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
por: Idel, Christian, et al.
Publicado: (2021)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

In vitro evaluation of photon and carbon ion radiotherapy in combination with cisplatin in head and neck squamous cell carcinoma cell lines
por: Fang, Xumeng, et al.
Publicado: (2023)

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity
por: Szturz, Petr, et al.
Publicado: (2020)

Association of Inflammation-Related Gene Polymorphisms With Susceptibility and Radiotherapy Sensitivity in Head and Neck Squamous Cell Carcinoma Patients in Northeast China
por: Li, Ying, et al.
Publicado: (2021)

CNN-Based Quality Assurance for Automatic Segmentation of Breast Cancer in Radiotherapy
por: Chen, Xinyuan, et al.
Publicado: (2020)

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
por: Oosting, Sjoukje F., et al.
Publicado: (2019)

Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma
por: Guo, Chen, et al.
Publicado: (2019)

HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
por: Augustin, Jeremy Gbenakpon, et al.
Publicado: (2020)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma
por: He, Yingzheng, et al.
Publicado: (2020)

Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

Editorial: “Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma”
por: Cao, Wei, et al.
Publicado: (2021)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Role of IGF2BPs in head and neck squamous cell carcinoma
por: Wu, Kainan, et al.
Publicado: (2022)

CircRNAs: Roles in regulating head and neck squamous cell carcinoma
por: Han, Xiao, et al.
Publicado: (2022)

Quality assurance devices for dynamic conformal radiotherapy
por: Wong, Victy Y.W.
Publicado: (2004)

Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials
por: Faught, Austin M., et al.
Publicado: (2013)

Image-Guided Radiotherapy for Locally Advanced Head and Neck Cancer
por: Nguyen, Nam P., et al.
Publicado: (2013)

Quality assurance of dysphagia-optimised intensity modulated radiotherapy treatment planning for head and neck cancer
por: Tyler, Justine, et al.
Publicado: (2021)

Machine Learning-Based Quality Assurance for Automatic Segmentation of Head-and-Neck Organs-at-Risk in Radiotherapy
por: Luan, Shunyao, et al.
Publicado: (2023)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma
por: Yang, Jian, et al.
Publicado: (2020)

Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Liu, Guohong, et al.
Publicado: (2021)

Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
por: dos Santos, Lucas V., et al.
Publicado: (2021)

The Identification of Stemness-Related Genes in the Risk of Head and Neck Squamous Cell Carcinoma
por: Feng, Guanying, et al.
Publicado: (2021)

Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
por: Hyytiäinen, Aini, et al.
Publicado: (2021)

Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma
por: Zhao, Sufeng, et al.
Publicado: (2022)

Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yaoting, et al.
Publicado: (2022)

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
por: Miao, Xiangwan, et al.
Publicado: (2022)

The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
por: Damasio, Marcos Paulo S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14ne6jgqko9piujenv5pdglcks